MIM
FRLN

Monashee Investment Management’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Monashee Investment Management’s Portfolio FRLN Stock Details FRLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6,327
Closed -$1.48M – 326
2020
Q3 		$1.48M Buy
+6,327
New +$1.59M 0.32% 78

Other funds holding FRLN

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Monashee Investment Management's FRLN Position: Q4 2020 in Review

Monashee Investment Management sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q4 2020, closing a stake of 6,327 shares — an estimated $1.48M sold.

Monashee Investment Management first reported a position in FRLN in Q3 2020 and held it in 1 quarter. The position peaked at $1.48M in Q3 2020. 20 funds tracked by Wall St. Rank hold FRLN as of Q4 2020.

  • Monashee Investment Management reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q4 2020 after selling out during the quarter.
  • Monashee Investment Management sold 6,327 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q4 2020, an estimated $1.48M.
  • Monashee Investment Management first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2020 and held it in 1 quarter.
  • Monashee Investment Management's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $1.48M in Q3 2020.
  • 20 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q4 2020.

Based on Monashee Investment Management's 13F filing for Q4 2020, filed 11 Feb 2021.